Physiomics (PYC) RNS Announcements

Add to Alert list
Date Time Source Announcement
09 Jan 2023 07:00 AM
RNS
Completion of PARTNER study
22 Nov 2022 04:00 PM
RNS
Result of AGM
10 Nov 2022 08:50 AM
RNS
Contract award
09 Nov 2022 07:00 AM
RNS
PYC to present and exhibit at SITC Annual Meeting
27 Oct 2022 07:00 AM
RNS
Annual Report and AGM Notice
14 Oct 2022 07:00 AM
RNS
Conference Attendance
12 Oct 2022 07:00 AM
RNS
Contract Award
04 Oct 2022 07:00 AM
RNS
Contract Award
29 Sep 2022 07:00 AM
RNS
Interim Results
09 Sep 2022 07:00 AM
RNS
Notice of Results
01 Sep 2022 07:00 AM
RNS
Appointment of Independent Non-Executive Director
07 Jul 2022 07:00 AM
RNS
Trading update
04 May 2022 07:00 AM
RNS
Physiomics expands technical team
29 Apr 2022 10:00 AM
RNS
Issue of Options
08 Apr 2022 07:00 AM
RNS
Contract award
29 Mar 2022 07:00 AM
RNS
Appointment of Independent Non-Executive Director
07 Mar 2022 07:00 AM
RNS
Interim Results
02 Mar 2022 07:00 AM
RNS
Contract award
02 Mar 2022 07:00 AM
RNS
Notice of Interim Results & Investor Presentation
23 Feb 2022 07:00 AM
RNS
Board Changes
21 Feb 2022 10:00 AM
RNS
DoseMeRx Update
19 Jan 2022 12:30 PM
RNS
Issue of Equity
22 Dec 2021 12:00 PM
RNS
Contract award
13 Dec 2021 07:00 AM
RNS
Merck Contracts
23 Nov 2021 03:30 PM
RNS
Result of AGM
12 Nov 2021 12:00 PM
RNS
Conference presentation
12 Nov 2021 12:00 PM
RNS
Conference presentation
27 Oct 2021 01:00 PM
RNS
Posting of Annual Report and AGM Notice
22 Oct 2021 07:00 AM
RNS
Contract awards
30 Sep 2021 03:00 PM
RNS
Results Presentation and DoseMeRx Update
30 Sep 2021 07:00 AM
RNS
Final Results
16 Sep 2021 02:45 PM
RNS
PARNTER study recruits first patient
15 Sep 2021 07:00 AM
RNS
Notice of Results and Investor Presentation
31 Aug 2021 07:00 AM
RNS
Physiomics hires Head of Business Development
19 Jul 2021 07:00 AM
RNS
Physiomics expands technical team
29 Jun 2021 09:16 AM
RNS
Director Dealing
21 May 2021 04:40 PM
RNS
Director Dealing
21 May 2021 07:00 AM
RNS
Contract awards
14 May 2021 07:00 AM
RNS
Contract award
11 May 2021 07:00 AM
RNS
Contract award
10 May 2021 07:00 AM
RNS
Trading update
09 Apr 2021 02:00 PM
RNS
Conference presentation
22 Mar 2021 07:00 AM
RNS
Director/PDMR Shareholding
12 Mar 2021 07:00 AM
RNS
Presentation and Q&A on Company's Interim Results
04 Mar 2021 07:00 AM
RNS
Interim Results Presentation
02 Mar 2021 10:12 AM
RNS
Issue of Options
01 Mar 2021 07:00 AM
RNS
Interim Results
15 Feb 2021 07:00 AM
RNS
ValiRx Agreement
18 Dec 2020 07:00 AM
RNS
Holding(s) in Company
17 Dec 2020 02:00 PM
RNS
Partnership with TRHC's DoseMeRx®

Physiomics plc is a UK-based company that uses mathematical models to help develop cancer treatments and personalized medicine. Services include Virtual Tumor modeling: A combination of proprietary and industry standard technologies that predict the effects of cancer treatments and drugs, Answering R&D questions: Helping clients de-risk drug development and build confidence in a molecule's clinical potential and Predicting therapeutic windows: Helping clients achieve a more quantitative understanding of new molecules.

PYC share price listed at 231p in 2004.

UK 100

Latest directors dealings